Transgender hormone therapy is quizlet

Submitted by anxiousahsoka.

Federal government websites often end in. The site is secure. Preview improvements coming to the PMC website in October Learn More or Try it out now. Recently, gender-affirming hormone therapy for gender incongruence has become an issue in various countries and organizations with various guidelines. In South Korea, several clinical treatments are also used with many possible options.

Transgender hormone therapy is quizlet

.

Softening of skin, loss of facial hair, enlargement of breast, and decreased libido, spontaneous erections and testicular volume can occur in the first 3—6 months of treatment.

.

Gender-affirming hormone therapy helps transgender and other gender-nonconforming people align their bodies with their gender identity. Not all transgender trans people are interested in hormone therapy. However, many transgender people, particularly binary transgender people, turn to hormones to affirm their gender. Gender-affirming hormone therapy is comprised of masculizing hormone therapy used in trans men and feminizing hormone therapy used in trans women. This article describes the goals of gender-affirming hormone therapy, how the treatment is administered, and the different types of hormones used.

Transgender hormone therapy is quizlet

Transgender hormone therapy , also called hormone replacement therapy HRT or gender-affirming hormone therapy GAHT , is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity. This form of hormone therapy is given as one of two types, based on whether the goal of treatment is masculinization or feminization :. Eligibility for transgender hormone therapy may be concluded by assessing a patient for gender dysphoria or persistent gender incongruence, though many medical institutions now used an informed consent model. This model ensures patients are informed of the procedure process, including possible benefits and risks, while removing many of the historical barriers needed to start hormone therapy. Treatment guidelines for therapy have been developed by several medical associations. Some intersex people may also undergo hormone therapy, either starting in childhood to confirm the sex they were assigned at birth , or later in order to align their sex with their gender identity.

Sissy bbc

Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Next page. Most changes including fat redistribution and increased muscle mass are reversible, while deepening voice and male pattern hair loss are irreversible. Measure serum estradiol and testosterone levels every 3 months with dose changes and maintain them at the level for premenopausal female. Clinicians should be aware of unknown risks associated with residual breast tissue and limitations of mammography in FTM individuals who undergo a mastectomy. Acne of the face, chest, and back, usually accompanied by hair growth, can commonly develop, or worsen in the first year of testosterone use. It is no longer considered a mental disorder. Exogenous testosterone can reduce breast glandular tissues with fibrous transformation without increasing breast size [ 21 , 22 , 23 ]. Spironolactone may result in side effects, including hyperkalemia, frequency of urination, low blood pressure. Exp Clin Endocrinol Diabetes. Gender-affirming sex hormone replacement therapy inducing the transition of physical characteristics has been demonstrated to improve mental health outcomes as a cardinal concern for transgender persons [ 64 ]. Copy Download.

.

Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Table 2 Hormone regimens in transgender persons. Ann Intern Med. If testosterone level is lower than the lower limit of the cisgender male physiologic levels, the dose can be elevated carefully. WPATH; However, it is unclear whether gender-affirming testosterone treatment increases risks of adverse cardiovascular outcomes [ 5 ]. J Urol. If anyone knows anything let me know. As with cisgender women, FTM individuals with cervical tissues should be provided with cervical cancer screening tests after age Breslow L. Cyproterone acetate has been reported to have a higher testosterone suppression efficacy than spironolactone [ 37 ]. FTM on testosterone may experience lowering of voice within the first 3 months and significant voice deepening within 9—12 months [ 16 , 17 ], although the degree of change is insufficient for some patients [ 18 , 19 ]. The Yogyakarta Principles plus additional principles and state obligations on the application of international human rights law in relation to sexual orientation, gender identity, gender expression and sex characteristics to complement the Yogyakarta Principles. Obstet Gynecol Sci.